Kilitch Drugs

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE729D01010
NSEID: KILITCH
BSEID: 524500

INR

335.70

-1.7 (-0.5%)

BSENSE

Dec 19

BSE+NSE Vol: 4.66 k

{
  "main_header": {
    "sid": 189669,
    "name": "Kilitch Drugs",
    "stock_name": "Kilitch Drugs",
    "full_name": "Kilitch Drugs (India) Ltd",
    "name_url": "stocks-analysis/kilitch-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "335.70",
    "chg": -1.7,
    "chgp": "-0.5%",
    "dir": -1,
    "prev_price": "337.40",
    "mcapval": "593.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524500,
    "symbol": "KILITCH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE729D01010",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "4.66 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kilitch-drugs-189669-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kilitch Drugs (India) Sees Shift in Technical Momentum Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-faces-bearish-momentum-amid-technical-downturn-3752641",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KilitchDrugsInd_technicaldot_3752641.png",
        "date": "2025-12-09 08:02:55",
        "description": "Kilitch Drugs (India), a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting evolving market dynamics and investor sentiment. Recent data reveals a transition in key technical indicators, signalling a more cautious outlook as the stock navigates a challenging environment."
      },
      {
        "title": "Why is Kilitch Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kilitch-drugs-fallingrising-3751951",
        "imagepath": "",
        "date": "2025-12-09 00:01:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Performance and Market Comparison</strong></p>\n<p>The stock’s recent trajectory has been notably weak. Over the past week, Kilitch Drugs has declined by 5.75%, substantially underperforming the Sensex, which recorded a modest loss of 0.63% during the same period. The one-month performance is even more concerning, with the stock falling 15.10% while the Sensex gained 2.27%. Year-to-date, Kilitch Drugs has barely moved, registering a negligible 0.02% increase compared to the Sensex’s robust 8.91% gain. Over the last year, the stock has declined by 4.39%, whereas the benchmark index rose by 4.15%. These figures highlight a clear divergence between Kilitch Drugs and the broader market, signalling investor caution or negative sentiment specific to the company.</p>\n<div class=\"pro..."
      },
      {
        "title": "Is Kilitch Drugs technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kilitch-drugs-technically-bullish-or-bearish-3747608",
        "imagepath": "",
        "date": "2025-12-05 08:23:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Kilitch Drugs’ Current Market Position</strong></p>\n<p>Kilitch Drugs is trading at ₹343.25, marginally above its previous close of ₹341.80. The stock’s 52-week range spans from ₹271.30 to ₹500.05, indicating significant volatility over the past year. Today’s intraday movement saw a high of ₹360.00 and a low of ₹337.95, reflecting some short-term price fluctuations.</p>\n<p>While the stock price remains comfortably above its yearly low, it is still well below the 52-week high, suggesting that the stock has not regained its peak momentum. This price behaviour is an important backdrop when analysing the technical indicators.</p>\n<p><strong>Technical Trend and Moving Averages</strong></p>\n<p>The overall technical trend for Kilitch Drugs recently shifted from bearish to mildly bearish ..."
      },
      {
        "title": "Kilitch Drugs (India) Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-technical-momentum-shifts-amid-mixed-market-signals-3747477",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KilitchDrugsInd_technicaldot_3747477.png",
        "date": "2025-12-05 08:01:12",
        "description": "Kilitch Drugs (India) has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish indicators across multiple timeframes. Recent market data reveals a subtle transition in price dynamics, with key technical parameters signalling a cautious outlook for the pharmaceutical company amid broader sector trends."
      },
      {
        "title": "Kilitch Drugs (India) Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-shares-shift-to-bearish-momentum-amid-technical-downgrade-3745177",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KilitchDrugsInd_technicaldot_3745177.png",
        "date": "2025-12-04 08:01:15",
        "description": "Kilitch Drugs (India) has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across key indicators. As the stock navigates a challenging phase within the Pharmaceuticals & Biotechnology sector, recent evaluation adjustments highlight evolving market dynamics and investor sentiment."
      },
      {
        "title": "Kilitch Drugs (India) Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-technical-momentum-shifts-amid-mixed-market-signals-3742734",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KilitchDrugsInd_technicaldot_3742734.png",
        "date": "2025-12-03 08:01:41",
        "description": "Kilitch Drugs (India), a player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of market forces and analytical perspectives. Recent evaluation adjustments highlight a transition in price trends and technical indicators, offering investors a detailed view of the stock’s current positioning within a volatile market environment."
      },
      {
        "title": "Kilitch Drugs Sees Revision in Market Evaluation Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-downgraded-to-sell-by-marketsmojo-amid-weak-financial-and-technical-signals-3738120",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KilitchDrugs_mojoScore_3738120.png",
        "date": "2025-12-01 10:09:02",
        "description": "Kilitch Drugs has experienced a revision in its market evaluation, reflecting a shift in analytical perspective driven by recent financial and technical developments. The pharmaceutical company’s assessment now reflects a more cautious outlook, influenced by a combination of flat financial trends, valuation considerations, and technical indicators."
      },
      {
        "title": "Is Kilitch Drugs overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kilitch-drugs-overvalued-or-undervalued-3730110",
        "imagepath": "",
        "date": "2025-11-26 08:14:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics and Financial Health</strong></p>\n<p>Kilitch Drugs trades at a price-to-earnings (PE) ratio of approximately 22.3, which is moderate within the pharmaceutical industry context. Its price-to-book value stands at 2.32, indicating that the stock is priced at more than twice its book value, a common scenario for companies with growth potential in this sector. The enterprise value to EBITDA ratio of 19.36 suggests that the market values the company at nearly 19.4 times its earnings before interest, taxes, depreciation, and amortisation, a figure that is neither excessively high nor particularly low.</p>\n<p>Importantly, the company’s PEG ratio is notably low at 0.41, signalling that the stock’s price is relatively inexpensive compared to its earnings growth rate. This is a positi..."
      },
      {
        "title": "Kilitch Drugs (India) Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-faces-bearish-momentum-amid-technical-downgrade-3727313",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KilitchDrugsInd_technicaldot_3727313.png",
        "date": "2025-11-25 08:01:27",
        "description": "Kilitch Drugs (India) has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across key indicators. The pharmaceutical company’s stock price movements and technical parameters suggest evolving market sentiment amid broader sector dynamics."
      }
    ],
    "total": 267,
    "sid": "189669",
    "stock_news_url": "https://www.marketsmojo.com/news/kilitch-drugs-india-189669"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "We are hereby submitting the copy publication of extract of financial results for the quarter ended 30th September 2025",
      "source": "BSE"
    },
    {
      "caption": "Monitoring Agency Report",
      "datetime": "14-Nov-2025",
      "details": "We are submitting herewith the report received from monitoring agency for the quarter ended 30th September 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "14-Nov-2025",
      "details": "We are submitting herewith the Press Release of Financial Results for H126",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19",
          "dt": "2019-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Kilitch Drugs (India) Sees Shift in Technical Momentum Amid Market Volatility

2025-12-09 08:02:55

Kilitch Drugs (India), a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting evolving market dynamics and investor sentiment. Recent data reveals a transition in key technical indicators, signalling a more cautious outlook as the stock navigates a challenging environment.

Why is Kilitch Drugs falling/rising?

2025-12-09 00:01:42

Short-Term Price Performance and Market Comparison

The stock’s recent trajectory has been notably weak. Over the past week, Kilitch Drugs has declined by 5.75%, substantially underperforming the Sensex, which recorded a modest loss of 0.63% during the same period. The one-month performance is even more concerning, with the stock falling 15.10% while the Sensex gained 2.27%. Year-to-date, Kilitch Drugs has barely moved, registering a negligible 0.02% increase compared to the Sensex’s robust 8.91% gain. Over the last year, the stock has declined by 4.39%, whereas the benchmark index rose by 4.15%. These figures highlight a clear divergence between Kilitch Drugs and the broader market, signalling investor caution or negative sentiment specific to the company.

Is Kilitch Drugs technically bullish or bearish?

2025-12-05 08:23:26

Overview of Kilitch Drugs’ Current Market Position

Kilitch Drugs is trading at ₹343.25, marginally above its previous close of ₹341.80. The stock’s 52-week range spans from ₹271.30 to ₹500.05, indicating significant volatility over the past year. Today’s intraday movement saw a high of ₹360.00 and a low of ₹337.95, reflecting some short-term price fluctuations.

While the stock price remains comfortably above its yearly low, it is still well below the 52-week high, suggesting that the stock has not regained its peak momentum. This price behaviour is an important backdrop when analysing the technical indicators.

Technical Trend and Moving Averages

The overall technical trend for Kilitch Drugs recently shifted from bearish to mildly bearish ...

Kilitch Drugs (India) Technical Momentum Shifts Amid Mixed Market Signals

2025-12-05 08:01:12

Kilitch Drugs (India) has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish indicators across multiple timeframes. Recent market data reveals a subtle transition in price dynamics, with key technical parameters signalling a cautious outlook for the pharmaceutical company amid broader sector trends.

Kilitch Drugs (India) Technical Momentum Shifts Amid Mixed Market Signals

2025-12-04 08:01:15

Kilitch Drugs (India) has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across key indicators. As the stock navigates a challenging phase within the Pharmaceuticals & Biotechnology sector, recent evaluation adjustments highlight evolving market dynamics and investor sentiment.

Kilitch Drugs (India) Technical Momentum Shifts Amid Mixed Market Signals

2025-12-03 08:01:41

Kilitch Drugs (India), a player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of market forces and analytical perspectives. Recent evaluation adjustments highlight a transition in price trends and technical indicators, offering investors a detailed view of the stock’s current positioning within a volatile market environment.

Kilitch Drugs Sees Revision in Market Evaluation Amidst Mixed Financial Signals

2025-12-01 10:09:02

Kilitch Drugs has experienced a revision in its market evaluation, reflecting a shift in analytical perspective driven by recent financial and technical developments. The pharmaceutical company’s assessment now reflects a more cautious outlook, influenced by a combination of flat financial trends, valuation considerations, and technical indicators.

Is Kilitch Drugs overvalued or undervalued?

2025-11-26 08:14:05

Valuation Metrics and Financial Health

Kilitch Drugs trades at a price-to-earnings (PE) ratio of approximately 22.3, which is moderate within the pharmaceutical industry context. Its price-to-book value stands at 2.32, indicating that the stock is priced at more than twice its book value, a common scenario for companies with growth potential in this sector. The enterprise value to EBITDA ratio of 19.36 suggests that the market values the company at nearly 19.4 times its earnings before interest, taxes, depreciation, and amortisation, a figure that is neither excessively high nor particularly low.

Importantly, the company’s PEG ratio is notably low at 0.41, signalling that the stock’s price is relatively inexpensive compared to its earnings growth rate. This is a positi...

Kilitch Drugs (India) Technical Momentum Shifts Amid Mixed Market Signals

2025-11-25 08:01:27

Kilitch Drugs (India) has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across key indicators. The pharmaceutical company’s stock price movements and technical parameters suggest evolving market sentiment amid broader sector dynamics.